Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer

Chemotherapy is the primary treatment for advanced non-small-cell lung cancer (NSCLC). However, related dose-dependent toxicity limits its clinical use. Therefore, it is necessary to explore new strategies for improving the clinical outcomes while reducing the side effects of chemotherapy in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zhang, Yan, Zhang, GuangPeng, Xiang, Li, Pang, HaoWen, Xiong, Kang, Lu, Yun, Li, JianMei, Dai, Jie, Lin, Sheng, Fu, ShaoZhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856057/
https://www.ncbi.nlm.nih.gov/pubmed/35156493
http://dx.doi.org/10.1080/10717544.2022.2036871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856057/
https://www.ncbi.nlm.nih.gov/pubmed/35156493
http://dx.doi.org/10.1080/10717544.2022.2036871

Ejemplares similares